News

New province-wide screening supports more personalized pregnancy care while reducing unnecessary interventions.

A research team from McMaster University, the University of Ottawa, BORN Ontario and the University of Toronto is conducting a survey to better understand pregnancy care professionals’ knowledge, attitudes, preferences and practices related to RSV prevention products.

Newborn Screening Ontario (NSO) and the CHEO Research Institute are conducting the INFANT Study to explore how genomic newborn screening could help identify rare genetic conditions earlier in life.

BORN Ontario Scientific Director Dr. Mark Walker has led an international team of experts in a new seminar published in The Lancet examining the latest evidence on pre-eclampsia.

Join BORN Ontario for a practical webinar on Prenatal Screening for Aneuploidy in Ontario, designed to help health-care providers stay up to date on current screening pathways, counselling guidance and available resources.

This webinar highlights the health AI research happening at BORN Ontario, from foundational methods to real-world applications in perinatal and child health.

Understanding your risk for preterm preeclampsia early in pregnancy can help guide your care. When recommended by a healthcare provider, low-dose aspirin when recommended, can help reduce risks and support safer outcomes for both parent and baby. Talk to your healthcare provider about getting screened.

Black birthing people and families continue to experience inequities in maternal, perinatal and infant health outcomes. Understanding these inequities—and using data responsibly to help address them—is an important part of advancing health equity.

Join the Annual Respiratory Syncytial Virus (RSV) Conference on September 23, 2026, for a virtual program focused on bringing the latest RSV research and evidence into clinical practice.

Hospitals across Ontario are reporting an increase in families declining the recommended intramuscular (IM) Vitamin K injection at birth. While this decision may be perceived as low risk, refusal increases the risk of Vitamin K Deficiency Bleeding (VKDB)—a rare but potentially serious and preventable condition in newborns.